Health officials have reported a rise in human metapneumovirus (HMPV) infections among children ages 14 and under in China, but the exact magnitude of this uptick is unclear.

(HealthDay News) — Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

So, which respiratory virus invaded your cells? Several types of viruses could be the culprit: respiratory syncytial virus ...

There may be an increase in vaccine hesitancy but it isn't too late for those who would still want them, one doctor says.

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.

Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by ...

As temperatures drop, the flu and respiratory syncytial virus (RSV) are making a comeback, according to Jacob Pierce, an infectious disease doctor at ECU Health ...

The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...

Dr. April Miller with Mississippi Public Health Institute lists some RSV symptoms to look for. “The symptoms are typically ...